Ease of Use of the iGlarLixi SoloStar Pen from the LixiLan ONE CAN Pen Sub-Study: Questionnaire Findings from People Living with Type 2 Diabetes and Their HealthCare Providers

INTRODUCTION: For people with type 2 diabetes mellitus who do not achieve glycated hemoglobin A1C targets after treatment with basal insulin therapies, additional therapy with a glucagon-like peptide-1 receptor agonist (GLP-1 RA) may be required. One option is to use a once-daily fixed-ratio combina...

Descripción completa

Detalles Bibliográficos
Autores principales: Yale, Jean-François, Roborel de Climens, Aude, Aggarwal, Naresh, Dex, Terry, Gerstein, Hertzel C., Harris, Stewart, Hramiak, Irene, Stewart, John, Leiter, Lawrence A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9943797/
https://www.ncbi.nlm.nih.gov/pubmed/36574199
http://dx.doi.org/10.1007/s13300-022-01353-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9943797/
https://www.ncbi.nlm.nih.gov/pubmed/36574199
http://dx.doi.org/10.1007/s13300-022-01353-6

Ejemplares similares